跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VANTOBRA 170 MG SOLUCION PARA INHALACION POR NEBULIZADOR - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
VANTOBRA 170 MG SOLUCION PARA INHALACION POR NEBULIZADOR
Approved
STANDARD
VANTOBRA 170 MG SOLUCION PARA INHALACION POR NEBULIZADOR
Pari Pharma Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 27, 2020
Approval ID
e69dc2272e6ebbeb
Company
Pari Pharma Gmbh
Type
Standard
Approval Details
Approval Id
e69dc2272e6ebbeb
Drug Cima Aemps Name
VANTOBRA 170 MG SOLUCION PARA INHALACION POR NEBULIZADOR
Register Number
181350001
Holder Company Name
Pari Pharma Gmbh
Marketing Company Name
Pari Pharma Iberia S.L.
Holder Company Detail Path
/organization/pari-pharma-gmbh
Authorization Date
2020-10-27
Dosage Form
SOLUCIÓN PARA INHALACIÓN POR NEBULIZADOR
Dose
170 mg
Route Of Administration
VÍA INHALATORIA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Pari Pharma Gmbh
Company Detail Path
/organization/pari-pharma-gmbh
Company Information
Pharmaceutical Company Name
PARI Pharma GmbH
Country Name
Germany
City Name
gräfelfing,bayern,country_de
Address
Lochhamer Schlag 21
Website
http://www.paripharma.com
Active Ingredients
TOBRAMICINA
170 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 27, 2020
Approval ID
e69dc2272e6ebbeb
Type
Standard
Back to CIMA-AEMPS Approvals